Results
|
|
1.
|
|
|
|
2.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
|
3.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
|
|
4.
|
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors:
Year: 2013
Citation: - Eurointervention. 9(3):308-15, 2013 Jul.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R
|
